POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLD) IN ADULT LIVER TRANSPLANTED PATIENTS WITH IMMUNOLOGICAL DISEASES

被引：0
|
作者：
Zimmermann, Tim [1 ]
Tripkovic, Vuk [1 ]
Hoppe-Lotichius, Maria [2 ]
Wehler, Thomas C.
Biesterfeld, Stefan [3 ]
Barreiros, Ana Paula [1 ]
Galle, Peter R. [1 ]
Otto, Gerd
Schuchmann, Marcus [1 ]
机构：
[1] Johannes Gutenberg Univ Mainz, Dept Med 1, D-6500 Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Dept Med 3, Mainz, Germany
[3] Johannes Gutenberg Univ Mainz, Inst Pathol, D-6500 Mainz, Germany
来源：
LIVER TRANSPLANTATION | 2009年 / 15卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S198 / S198
页数：1
相关论文
共 50 条
  • [1] Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD)
    Zimmermann, Tim
    Hoppe-Lotichius, Maria
    Tripkovic, Vuk
    Barreiros, Ana P.
    Wehler, Thomas C.
    Zimmermann, Anca
    Schattenberg, Jorn M.
    Heise, Michael
    Biesterfeld, Stefan
    Galle, Peter R.
    Otto, Gerd
    Schuchmann, Marcus
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2010, 21 (03) : 208 - 215
  • [2] Post-transplant Lymphoproliferative Disorders (PTLD) in Kidney Transplant
    Campise, Mariarosaria
    Malvica, Silvia
    Alfieri, Carlo
    Verdesca, Simona
    Regalia, Anna
    Castellano, Giuseppe
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [3] Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation?
    Aucejo, F
    Rofaiel, G
    Miller, C
    JOURNAL OF HEPATOLOGY, 2006, 44 (01) : 19 - 23
  • [4] Post-transplant Lymphoproliferative Disorders in Liver Transplanted Patients: A Single-centre Experience
    Marino, D.
    Burra, P.
    Boccagni, P.
    Calabrese, F.
    Canova, F.
    Trentin, C.
    Boso, C.
    Solda, C.
    Angeli, P.
    Aversa, S. M. L.
    ANTICANCER RESEARCH, 2010, 30 (06) : 2383 - 2391
  • [5] Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)
    Nalesnik, MA
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1998, 20 (3-4): : 325 - 342
  • [6] Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)
    Michael A. Nalesnik
    Springer Seminars in Immunopathology, 1998, 20 : 325 - 342
  • [7] Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era
    Ghobrial, IM
    Habermann, TM
    Ristow, KM
    Ansell, SM
    Macon, W
    Geyer, SM
    McG egor, CG
    LEUKEMIA & LYMPHOMA, 2005, 46 (02) : 191 - 196
  • [8] Post-transplant lymphoproliferative disorder (PTLD)
    Petrik, D. W.
    Lai, R.
    Pearcey, R. G.
    CLINICAL ONCOLOGY, 2007, 19 (02) : 163 - 164
  • [9] Post-transplant lymphoproliferative disorders (PTLD) in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression
    Shapiro, R
    Nalesnik, M
    McCauley, J
    Fedorek, S
    Jordan, ML
    Scantlebury, VP
    Vivas, C
    Ellis, D
    Lombardozzi-Lane, S
    Randhawa, P
    Johnston, J
    Hakala, TR
    Simmons, RL
    Fung, JJ
    Starzl, TE
    TRANSPLANTATION, 1999, 67 (07) : S218 - S218
  • [10] Post-transplant lymphoproliferative disorders in a cohort of liver-transplanted adult patients from a reference hospital in Bogota, Colombia
    Jurado, Leonardo F.
    Gomez-Aldana, Andros
    Tapias, Monica
    Caceres, Daniela
    Vera, Alonso
    del Pilar Lopez-PanquevalA, Rocio
    Andrade, Rafael E.
    BIOMEDICA, 2020, 40 (03):
12345